Volume 5, Issue 1 (Summer 2019)
SJNMP 2019, 5(1): 94-105 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Gharekhanloo F, Mohammad Gholi Mezerji, Shamsizadeh M. Young Women with Breast Cancer: A Cross-Sectional Descriptive Study Over 3 Years. SJNMP 2019; 5 (1) :94-105
URL: http://sjnmp.muk.ac.ir/article-1-187-en.html
URL: http://sjnmp.muk.ac.ir/article-1-187-en.html
1- Hamadan University of Medical Sciences
2- Hamadan University of Medical Sciences , mortezashamsizadeh@gmail.com
2- Hamadan University of Medical Sciences , mortezashamsizadeh@gmail.com
Abstract: (4093 Views)
Background & Aim: the breast cancer is the most common malignant tumor in women in recent years' incidence in young women is increased. According to dense breast in this group sensitivity of mammography is decreased. The aim of this study was to investigate young women with breast cancer.
Materials & Methods: In this cross-sectional study, 2160 patients who referred to the Hamadan's Mehr Imaging Center during the October of 2015 to October 2018, 220 patients (30 to 20 years old) were included in the study. Patients were selected by available sampling method as research sample. All patients who came to the study were enrolled according to the inclusion criteria. Patients with suspected lesions were referred for further evaluation and biopsy. Also, definitive results were reported after pathology examination. Data analysis was performed by using descriptive and analytical tests in SPSS software V.21. The significance level was p < 0.05.
Results: Mean age of patient was 27.5 years. Approved malignancies in 16 patients were seen. %50 of patients were single. The minimum age is 23 years. Most frequent symptom was palpable mass. About 2 of patient have positive family history. The most pathology was invasive ductal carcinoma grade 3. About 25 % of mass was discovered in the lactation state. Mortality rate at 2 years was 25% which was during the breastfeeding period. Place of mass, degree of differentiation and type of pathology had a significant relationship with breast cancer (p=0.001).
Conclusion: Considering the significant incidence of breast cancer in the under-30 age group and the detection of cancer in about 40% of patients studied during lactation, there is a great need to pay close attention to the masses discovered during lactation. Rapid examination of mass and screening at an early age is also important.
Materials & Methods: In this cross-sectional study, 2160 patients who referred to the Hamadan's Mehr Imaging Center during the October of 2015 to October 2018, 220 patients (30 to 20 years old) were included in the study. Patients were selected by available sampling method as research sample. All patients who came to the study were enrolled according to the inclusion criteria. Patients with suspected lesions were referred for further evaluation and biopsy. Also, definitive results were reported after pathology examination. Data analysis was performed by using descriptive and analytical tests in SPSS software V.21. The significance level was p < 0.05.
Results: Mean age of patient was 27.5 years. Approved malignancies in 16 patients were seen. %50 of patients were single. The minimum age is 23 years. Most frequent symptom was palpable mass. About 2 of patient have positive family history. The most pathology was invasive ductal carcinoma grade 3. About 25 % of mass was discovered in the lactation state. Mortality rate at 2 years was 25% which was during the breastfeeding period. Place of mass, degree of differentiation and type of pathology had a significant relationship with breast cancer (p=0.001).
Conclusion: Considering the significant incidence of breast cancer in the under-30 age group and the detection of cancer in about 40% of patients studied during lactation, there is a great need to pay close attention to the masses discovered during lactation. Rapid examination of mass and screening at an early age is also important.
Type of Study: Research |
Subject:
Special
Received: 2018/11/5 | Revised: 2019/09/4 | Accepted: 2018/12/22 | Published: 2019/10/24 | ePublished: 2019/10/24
Received: 2018/11/5 | Revised: 2019/09/4 | Accepted: 2018/12/22 | Published: 2019/10/24 | ePublished: 2019/10/24
References
1. DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA: a cancer journal for clinicians. 2017;67(6):439-48. [DOI:10.3322/caac.21412]
2. Rheinbay E, Parasuraman P, Grimsby J, Tiao G, Engreitz JM, Kim J, et al. Recurrent and functional regulatory mutations in breast cancer. Nature. 2017;547(7661):55-60. [DOI:10.1038/nature22992]
3. Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H, et al. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer. Breast Cancer. 2017;24(5):667-72. [DOI:10.1007/s12282-017-0753-4]
4. Wang C, Kar S, Lai X, Cai W, Arfuso F, Sethi G, et al. Triple negative breast cancer in Asia: An insider's view. Cancer treatment reviews. 2017. [DOI:10.1016/j.ctrv.2017.10.014]
5. Nafissi N, Khayamzadeh M, Zeinali Z, Mohammadi G, Hosseini M, Akbari M. Breast Cancer in Iran, from Epidemiology, Clinicopathological and Biomarker Feature. Advances in Bioresearch. 2017;8(2).
6. SeyyedHosseini S, Asemi A, Shabani A, CheshmehSohrabi M. An infodemiology study on breast cancer in Iran: Health information supply versus health information demand in PubMed and Google Trends. The Electronic Library. 2018;36(2):258-69. [DOI:10.1108/EL-03-2017-0062]
7. Brinton LA, Brogan DR, Coates RJ, Swanson CA, Potischman N, Stanford JL. Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Menopause. 2018;25(11):1195-200. [DOI:10.1097/GME.0000000000001217]
8. Otaghvar HA, Hosseini M, Tizmaghz A, Shabestanipour G, Noori H. A review on metastatic breast cancer in Iran. Asian Pacific Journal of Tropical Biomedicine. 2015;5(6):429-33. [DOI:10.1016/j.apjtb.2015.02.001]
9. Jazayeri SB, Saadat S, Ramezani R, Kaviani A. Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. Cancer epidemiology. 2015;39(4):519-27. [DOI:10.1016/j.canep.2015.04.016]
10. Abachizadeh K, Moradi-Kouchi A, Ghanbari-Motlagh A, Kousha A, Shekarriz-Foumani R, Erfani A. Breast Cancer in Iran: levels, Variations and Correlates. Community Health (Salāmat-i ijtimāī). 2018;5(1):11-21.
11. Nafissi N, Khayamzadeh M, Zeinali Z, Pazooki D, Hosseini M, Akbari ME. Epidemiology and Histopathology of Breast Cancer in Iran versus Other Middle Eastern Countries. Middle East Journal of Cancer. 2018;9(3):243-51.
12. Mojarrab S, Rafei A, Akhondzadeh S, Jeddian A, Jafarpour M, Zendehdel K. Diseases and Health Outcomes Registry Systems in IR Iran: Successful Initiative to Improve Public Health Programs, Quality of Care, and Biomedical Research. Archives of Iranian Medicine (AIM). 2017;20(11).
13. Lubin F, Wax Y, Modan B. Role of Fat, Animal Protein, and Dietary Fiber in Breast Cancer Etiology: A Case-Control Study 2. JNCI: Journal of the National Cancer Institute. 1986;77(3):605-12. [DOI:10.1093/jnci/77.3.605]
14. DiSaia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DG. Clinical Gynecologic Oncology E-Book: Elsevier Health Sciences; 2017.
15. Vakili M, Pirdehghan A, Adimi M, Sadeghian M, Akhondi M. Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009. Journal of research in health sciences. 2014;14(3):210-3.
16. Hodgson D, van Leeuwen F, Ng A, Morton L, Henderson TO, editors. Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It's Not Just About Chest Radiation. American Society of Clinical Oncology educational book American Society of Clinical Oncology Meeting; 2017. [DOI:10.1200/EDBK_175668]
17. Henriksen EL, Carlsen JF, Vejborg IM, Nielsen MB, Lauridsen CA. The efficacy of using computer-aided detection (CAD) for detection of breast cancer in mammography screening: a systematic review. Acta Radiologica. 2018:0284185118770917. [DOI:10.1177/0284185118770917]
18. Helewa M, Levesque P, Provencher D, Lea R, Rosolowich V, Shapiro H. Breast cancer, pregnancy, and breastfeeding. Journal of obstetrics and gynaecology Canada: JOGC= Journal d'obstetrique et gynecologie du Canada: JOGC. 2002;24(2):164-80; quiz 81-4.
19. Chen Y, Chou S-HS, Blaschke EM, Specht MC, Lehman CD. Value of Mammography for Women 30-39 Years Old Presenting With Breast Symptoms. American Journal of Roentgenology. 2018:1-9. [DOI:10.2214/AJR.18.19591]
20. Qin J, White MC, Sabatino SA, Febo-Vázquez I. Mammography use among women aged 18-39 years in the United States. Breast cancer research and treatment. 2018;168(3):687-93. [DOI:10.1007/s10549-017-4625-6]
21. DeSantis CE, Jemal A. Re: Black-White Breast Cancer Incidence Trends: Effects of Ethnicity. JNCI: Journal of the National Cancer Institute. 2018. [DOI:10.1093/jnci/djy162]
22. Bhikoo R, Srinivasa S, Yu T-C, Moss D, Hill AG. Systematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia. Cancers. 2011;3(2):2382-401. [DOI:10.3390/cancers3022382]
23. Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A. Breast cancer in adolescents and young adults. Pediatric blood & cancer. 2018;65(12):e27397. [DOI:10.1002/pbc.27397]
24. Arkoob K, Al-Nsour M, Al-Nemry O, Al-Hajawi B. Epidemiology of breast cancer in women in Jordan: patient characteristics and survival analysis. Eastern Mediterranean Health Journal. 2010;16(10):1032. [DOI:10.26719/2010.16.10.1032]
25. Faradmal J, Roshanaei G, Mafi M, Sadighi-Pashaki A, Karami M. Application of Censored Quantile Regression to Determine Overall Survival Related Factors in Breast Cancer. Journal of research in health sciences. 2016;16(1):36-40.
26. Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S, et al. BRCA1 and BRCA2 mutation testing in young women with breast cancer. JAMA oncology. 2016;2(6):730-6. [DOI:10.1001/jamaoncol.2015.5941]
27. Deapen D. Breast implants and breast cancer: a review of incidence, detection, mortality, and survival. Plastic and reconstructive surgery. 2007;120(7):70S-80S. [DOI:10.1097/01.prs.0000286577.70026.5d]
28. Miglioretti DL, Rutter CM, Geller BM, Cutter G, Barlow WE, Rosenberg R, et al. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. Jama. 2004;291(4):442-50. [DOI:10.1001/jama.291.4.442]
29. Final Recommendation Statement: Breast Cancer: Screening. 2016.
30. Hall E, Kotsopoulos J, Finch A, Thompson I, Rosen B, Murphy J, et al. Impact of prophylactic bilateral salpingo-oophorectomy on bone health in BRCA mutation carriers: A prospective cohort study. American Society of Clinical Oncology; 2018. [DOI:10.1200/JCO.2018.36.15_suppl.1566]
31. Browne JE, Cannon LM, McDermott R, Ryan M, Fagan AJ. Pilot investigation into the use of an anthropomorphic breast sonography phantom as a training and assessment tool. Ultrasound in medicine & biology. 2017;43(11):2733-40. [DOI:10.1016/j.ultrasmedbio.2017.07.015]
32. Destounis S, Arieno A, Morgan R. New York State Breast Density Mandate: Follow‐up Data With Screening Sonography. Journal of Ultrasound in Medicine. 2017;36(12):2511-7. [DOI:10.1002/jum.14294]
33. Dinas K, Moschaki V, Grammanikou K, Zepiridis L, Pratilas G, Sotiriadis A, et al. Breast self-examination in Greek midwives and midwifery students. Neoplasma. 2018;65(6):980. [DOI:10.4149/neo_2018_171112N729]
34. Ghahremani L, Mousavi Z, Kaveh MH, Ghaem H. Self-Care Education Programs Based on a Trans-Theoretical Model in Women Referring to Health Centers: Breast Self-Examination Behavior in Iran. Asian Pacific journal of cancer prevention: APJCP. 2016;17(12):5133.
35. Bouya S, Balouchi A, Ahmadidarehsima S, Badakhsh M. Knowledge and Source of Information About Early Detection Techniques of Breast Cancer Among Women in Iran: A Systematic Review. Journal of cancer prevention. 2018;23(1):51. [DOI:10.15430/JCP.2018.23.1.51]
36. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition. 2017;36(1):11-48. [DOI:10.1016/j.clnu.2016.07.015]
37. Coughlin SS, Besenyi GM, Bowen D, De Leo G. Development of the Physical activity and Your Nutrition for Cancer (PYNC) smartphone app for preventing breast cancer in women. mHealth. 2017;3. [DOI:10.21037/mhealth.2017.02.02]
38. McGee J, Giannakeas V, Karlan B, Lubinski J, Gronwald J, Rosen B, et al. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted? Gynecologic oncology. 2017;145(2):346-51. [DOI:10.1016/j.ygyno.2017.02.032]
39. Corter AL, Quan ML, Wright FL, Kennedy ED, Simunovic MR, Shao J, et al. Scoping clinicians' perspectives on pre-treatment multidisciplinary care for young women with breast cancer. Journal of Multidisciplinary Healthcare. 2018;11:547 [DOI:10.2147/JMDH.S173735]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
